Senior / Executive Director, Preclinical Development

Morphocell Technologies Inc.; Laval (administrative region); Hybrid; CAD 150,000 - 230,000; Full time

Benefits offered by this job

Competitive compensation package

Benefits

Job summary

Morphocell Technologies Inc. in Laval, Canada, seeks a Senior/Executive Director, Preclinical Development to lead nonclinical strategy for its regenerative medicine liver programs. Reporting to the CSO, you will guide in vivo translational studies, oversee GLP/non-GLP work, and align with clinical and regulatory teams to enable IND/CTA pathways.

The role requires a PhD/MD/etc. with 10+ years in biotech/pharma, strong leadership, and experience with regulatory interactions.

Qualifications

• PhD/MD/DVM or equivalent with deep experience in preclinical/translational development.
• 10+ years in biotech/pharma with leadership responsibility in preclinical or translational programs.
• Proven ability to interact with regulatory agencies and lead regulatory submissions.

Responsibilities

• Develop and execute integrated nonclinical development strategies for cell therapy programs.
• Lead GLP/non-GLP pharmacology, toxicology, PK, and safety studies and data interpretation.
• Oversee large-animal PK/POC studies and pivotal preclinical programs for clinical advancement.
• Mentor a multidisciplinary team of ~10 preclinical scientists and collaborate cross-functionally.
• Author regulatory documents and manage external CROs, budgets, and timelines.

Skills

Leadership

Strategic thinking

Communication

Mentoring

Education

PhD, PharmD, DVM, MD or equivalent advanced degree

DABT certification (asset)

Job description

Morphocell Technologies is seeking an accomplished preclinical development leader to play a
pivotal role in advancing its regenerative medicine platform and lead nonclinical strategy for its
liver disease programs. Reporting to the Chief Scientific Officer, the Senior/Executive Director,
Preclinical Development will provide scientific, translational, and operational leadership across
all aspects of preclinical development, with an immediate focus on advancing the company's
acute liver failure (ALF) and acute-on-chronic liver failure (ACLF) programs toward clinical
readiness.
This executive will be responsible for shaping and executing integrated nonclinical development
strategies, overseeing critical proof-of-concept and pivotal studies, and ensuring robust
regulatory alignment to support global clinical submissions. The successful candidate will bring
deep expertise in in vivo pharmacology and translational science, along with a demonstrated
track record of advancing innovative therapeutic programs from discovery through IND/CTA enabling
studies and into the clinic.
As a key member of Morphocell's scientific leadership team, this individual will lead and mentor
a multidisciplinary preclinical group, collaborate closely with Discovery, Technical Operations,
Engineering, Regulatory Affairs, and Clinical Development functions, and serve as a trusted
scientific advisor to senior leadership. The role offers a unique opportunity to influence the
future direction of a rapidly growing biotechnology company developing transformative
therapies for patients with severe liver disease.

Key Responsibilities

• Develop and execute integrated preclinical development strategies that support progression of Morphocell's cell therapy programs from discovery through clinical development.
• the scientific design, execution, interpretation, and reporting of non-GLP and GLP pharmacology, pharmacokinetic, biocompatibility, toxicology, and safety studies.
• the company's next critical development milestones, including large-animal proof-of-concept studies and subsequent pivotal preclinical programs required for clinical advancement.
• Provide strategic oversight for the selection and utilization of relevant in vitro and in vivo animal models.
• preclinical data packages to identify scientific, translational, and regulatory risks while developing mitigation strategies that support successful clinical entry.
• nonclinical findings into compelling clinical and regulatory strategies supporting IND, CTA, and global health authority interactions.
• as the primary scientific lead for external preclinical partners and CROs, ensuring study quality, timeline adherence, budget management, and regulatory compliance.
• Author and review regulatory documentation, including study reports, Investigator's Brochures, briefing packages, and nonclinical sections of regulatory submissions.
• Lead, mentor, and develop a growing team of approximately 10 preclinical scientists,
• cross-functionally with Discovery, Technical Operations, Engineering, Regulatory Affairs, Quality, and Clinical Development teams to align scientific strategy with broader organizational objectives.
• complex scientific concepts, development risks, and strategic recommendations to executive leadership, investors, collaborators, and external stakeholders.
• Maintain awareness of emerging scientific advances, translational approaches, and evolving regulatory expectations in regenerative medicine, liver disease, and advanced therapeutics

Qualifications

Education & Experience

• PhD, PharmD, DVM, MD, or equivalent advanced degree in Pharmacology, Toxicology, Biological Sciences, Translational Medicine, or a related discipline; DABT certification is considered a strong asset.
• 10+ years of progressive biotechnology and/or pharmaceutical industry experience in preclinical or translational development, including leadership responsibility.
• Demonstrated success advancing therapeutic programs through preclinical development, regulatory submissions, and clinical entry, with direct experience interacting with regulatory agencies.
• Proven leadership experience managing multidisciplinary scientific teams and developing talent within a dynamic, growth-oriented environment.

Technical Expertise

• Deep expertise in in vivo pharmacology, translational research, and nonclinical development strategy, ideally within biologics, cell therapies, regenerative medicine, or advanced therapeutics.
• Strong experience designing and overseeing GLP and non-GLP studies across pharmacology, toxicology, safety assessment, pharmacokinetics, and biocompatibility.
• Experience with liver disease programs, hepatic biology, or liver-focused therapeutic development is an asset.
• Strong understanding of FDA, Health Canada, EMA, and ICH regulatory expectations related to nonclinical development and cell-based therapies.
• Experience managing external CROs and scientific collaborators while maintaining accountability for quality, timelines, and budgets.
• Strategic thinker capable of balancing scientific excellence with pragmatic execution in a fast-paced biotechnology environment.
• Collaborative, low-ego leader who is comfortable operating both strategically and tactically, adapting to the needs of a growing organization.
• Strong communicator with the executive presence required to influence cross-functional teams, external partners, and senior stakeholders.
• Demonstrated ability to build trust, develop teams, and serve as a stabilizing scientific leader during periods of organizational growth and program advancement.

Why Morphocell

• Join a dynamic team of professionals committed to pushing the boundaries of cell therapy.
• Contribute to groundbreaking advancements in the field of biotechnology.
• Opportunity for personal and professional growth in a fast-paced and collaborative environment.
• Competitive compensation package and benefits.